{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:41Z","timestamp":1761630461020},"reference-count":9,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,8,4]],"date-time":"2007-08-04T00:00:00Z","timestamp":1186185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1468-3083.2007.02287.x","type":"journal-article","created":{"date-parts":[[2007,8,7]],"date-time":"2007-08-07T03:01:55Z","timestamp":1186455715000},"page":"121-122","source":"Crossref","is-referenced-by-count":9,"title":["Granulomatous septal panniculitis associated with capecitabine (Xeloda\u00ae)"],"prefix":"10.1111","volume":"22","author":[{"given":"J","family":"Dalmau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Ro\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,20]]},"reference":[{"key":"e_1_2_2_2_2","unstructured":"Roche Laboratories Inc.Xeloda (capecitabine) prescribing information. USA 1998."},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.01.005"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-4-288"},{"key":"e_1_2_2_5_2","first-page":"S60","article-title":"Skin manifestations in vasculitis and erythema nodosum","volume":"24","author":"Atzeni F","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063905"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.122745a"},{"key":"e_1_2_2_8_2","first-page":"202","article-title":"Capecitabine induced cutaneous hyperpigmentation: report of a case","volume":"1","author":"Pui JC","year":"2002","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117244"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.3.367"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2007.02287.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2007.02287.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:32:49Z","timestamp":1697005969000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2007.02287.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,20]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1111\/j.1468-3083.2007.02287.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02287.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,20]]}}}